论文部分内容阅读
近年来,急性非淋巴细胞白血病(ANLL)的完全缓解率(CR率)有所提高。Freireich等(1976)报告应用DAOP方案(59例)CR率是70％:Gale等(1977)应用TAD方案(28例)CR率是79％。国内自1973年三尖杉酯碱药物问世以来疗效也有提高,苏州医学院报告(1980)应用HOAP方案(28例)CR率是82.1％。但是,对老年急性非淋巴细胞白血病的疗效是众说纷纭。兹将本院23例老年ANLL的疗效报告如下:
In recent years, the complete remission rate (CR rate) of acute non-lymphocytic leukemia (ANLL) has been increased. Freireich et al. (1976) reported a CR rate of 70% using the DAOP regimen (59 patients): Gale et al. (1977) applied the TAD regimen (28 patients) with a CR rate of 79%. The therapeutic effect of harringtonine alkaloids has also been increasing since 1973 in China. The CR rate of HOAP regimen (28 cases) reported by Suzhou Medical College (1980) was 82.1%. However, the efficacy of acute non-lymphocytic leukemia in elderly is controversial. Here are 23 cases of elderly ANLL curative effect reported as follows: